the aid library

LIST OPTIONS

Filter

6428

Sort by:

Direction:

Download (476)

View PDF (2614)

Video: Warning Signs in Pregnancy/NAMNA YA KUZITAMBUA DALILI ZA HATARI KATIKA UJAUZITO

Medical Aid Films (2011) C1

Swahili language version of Warning Signs in Pregnancy. It is a film showing warning signs for women to watch out for during pregnancy and how they can try to avoid complication and illness during pregnancy and childbirth. Translation thanks to Yussuf Hamad & Ritva Niemi

Download (128)

View PDF (218)

Bipolar Disorder. Parents’ Medication Guide for Bipolar Disorder in Children & Adolescents

American Academy of Child and Adolescent Psychiatry (2010) CC

This guide was developed by AACAP to give reliable information about medication used to treat bipolar disorder in children and adolescents to parents whose children have been diagnosed with the illness.

Download (155)

View PDF (288)

Understanding refugee trauma: for mental health professionals
recommended

The National Child Traumatic Stress Network NCTSN (2007) C1

Refugee children and adolescents exhibit resilience despite a history of trauma. However, trauma can affect a refugee child’s emotional and behavioral development. Mental health providers should consider how the refugee experience (e.g., exposure to hunger, thirst, and lack of shelter; injury an... more

Download (819)

View PDF (1710)

Management of MDR-TB: A field guide

Partners in Health, World Health Organization (2009) C_WHO

Multidrug-resistant tuberculosis (MDR-TB) and extensively drug-resistant tuberculosis (XDR-TB) increasingly occur in resource-constrained settings. In the context of a national response to MDR- and XDR-TB, health workers in TB clinics (in district hospitals and some accredited health centres) wil... more

Download (109)

View PDF (121)

Prevention and control of microbiological hazards in fresh fruits and vegetables: part 4: specific commodities: meeting report

World Health Organisation (WHO) (2023) C_WHO

In 2019, following a request from the Codex Committee on Food Hygiene (CCFH), the Codex Alimentarius Committee (CAC) approved new work at its 42nd Session on the development of guidelines for the control of Shiga toxin-producing Escherichia coli (STEC) in leafy vegetables and in sprouts. The obje... more

Download (245)

View PDF (328)

Therapeutics and COVID-19 (Living Guideline, 10 November 2023)

World Health Organization WHO (2023) C_WHO

WHO has updated its guidelines for COVID-19 therapeutics, with revised recommendations for patients with non-severe COVID-19. This is the 13th update to these guidelines. Updated risk rates for hospital admission in patients with non-severe COVID-19 The guidance includes updated risk rates for... hospital admission in patients with non-severe COVID-19. The current COVID-19 virus variants tend to cause less severe disease while immunity levels are higher due to vaccination, leading to lower risks of severe illness and death for most patients. This update includes new baseline risk estimates for hospital admission in patients with non-severe COVID-19. The new ‘moderate risk’ category now includes people previously considered to be high risk including older people and/or those with chronic conditions, disabilities, and comorbidities of chronic disease. The updated risk estimates will assist healthcare professionals to identify individuals at high, moderate or low risk of hospital admission, and to tailor treatment according to WHO guidelines: **High: **People who are immunosuppressed remain at higher risk if they contract COVID-19, with an estimated hospitalization rate of 6%. **Moderate: **People over 65 years old, those with conditions like obesity, diabetes and/or chronic conditions including chronic obstructive pulmonary disease, kidney or liver disease, cancer, people with disabilities and those with comorbidities of chronic disease are at moderate risk, with an estimated hospitalization rate of 3%. Low: Those who are not in the high or moderate risk categories are at low risk of hospitalization (0.5%). Most people are low risk. Review of COVID-19 treatments for people with non-severe COVID-19 WHO continues to strongly recommend nirmatrelvir-ritonavir (also known by its brand name ‘Paxlovid’) for people at high-risk and moderate risk of hospitalization. The recommendations state that nirmatrelvir-ritonavir is considered the best choice for most eligible patients, given its therapeutic benefits, ease of administration and fewer concerns about potential harms. Nirmatrelvir-ritonavir was first recommended by WHO in April 2022. If nirmatrelvir-ritonavir is not available to patients at high-risk of hospitalization, WHO suggests the use of molnupiravir or remdesivir instead. WHO suggests against the use of molnupiravir and remdesivir for patients at moderate risk, judging the potential harms to outweigh the limited benefits in patients at moderate risk of hospital admission. For people at low risk of hospitalization, WHO does not recommend any antiviral therapy. Symptoms like fever and pain can continue to be managed with analgesics like paracetamol. WHO also recommends against use of a new antiviral (VV116) for patients, except in clinical trials. The update also includes a strong recommendation against the use of ivermectin for patients with non-severe COVID-19. WHO continues to advise that in patients with severe or critical COVID-19, ivermectin should only be used in clinical trials. more

Download (184)

View PDF (103)

South Sudan: Health Cluster strategy 2023-2025

Health Cluster; World Health Organization WHO (2023) CC

South Sudan continues to struggle with a severe health crisis affecting 8.9 million people, primarily in flood- and conflict-affected regions with population movements (displacement and returns), and disease outbreaks. The nation's health system, heavily reliant on international aid, faces staffing ... more

Download (54)

View PDF (621)

Noncommunicable Diseases

PAHO - Pan American Health Organization (2023) CC

The term NCDs refers to a group of conditions that are not mainly caused by an acute infection, result in long-term health consequences and often create a need for long-term treatment and care. These conditions include cancers, cardiovascular disease, diabetes and chronic lung illnesses.

Download (14)

View PDF (10)

Diabetes Mellitus: Insights from Epidemiology, Biochemistry, Risk Factors, Diagnosis, Complications and Comprehensive Management

Alam, S.; Hasan, K.; Neaz, S.; et al. Molecular Diversity Preservation International MDPI (2021) CC2

Diabetes mellitus has become a serious and chronic metabolic disorder that results from a complex interaction of genetic and environmental factors, principally characterized by hyperglycemia, polyuria, and polyphagia. Uncontrolled high blood sugar can result in a host of diabetic complications. Prol... more

Download (63)

View PDF (40)

Strategic Framework for Enhancing Prevention and Control of mpox, 2024-2027

World Health Organization WHO (2024) C_WHO

Mpox continues to affect people around the world. A new framework released today by WHO will guide health authorities, communities and other stakeholders in preventing and controlling mpox outbreaks, eliminating human-to-human transmission of the disease, and reducing spillover of the virus from ani... more

Download (18)

View PDF (12)

非传染性疾病预防和控制：资源匮乏地区初级卫生保健指南 2012

World Health Organization (WHO) World Health Organization (WHO) (2023) C_WHO

The document, titled "Prevention and Control of Noncommunicable Diseases: Guidelines for Primary Health Care in Low-Resource Settings," provides the World Health Organization's (WHO) recommendations for managing noncommunicable diseases (NCDs) such as cancer, heart disease, diabetes, and chronic res... more

Download (16)

View PDF (9)

الوقاية من األمراض غير السارية ومكافحتها: المبادئ التوجيهية للرعاية الصحية األولية في ظروف شح الموارد

World Health Organization (WHO) World Health Organization (WHO) (2023) C_WHO

Download (6)

View PDF (8)

Noncommunicable diseases - Regional framework for action

World Health Organization (WHO) Regional Office for the Eastern Mediterranean World Health Organization (WHO) Regional Office for the Eastern Mediterranean (2024) C_WHO

The WHO EMRO webpage on the "Regional framework for action" outlines strategies for addressing noncommunicable diseases (NCDs) within the Eastern Mediterranean region. The framework provides a roadmap for countries to reduce the prevalence and impact of NCDs such as cardiovascular diseases, diabetes... more

Download (11)

View PDF (8)

Noncommunicable Diseases Fact Sheet

Pan American Health Organization PAHO (2024) C_WHO

Chronic noncommunicable diseases (NCDs) are the number one cause of death and disability in the world. The term NCDs refers to a group of conditions that are not mainly caused by an acute infection, result in long-term health consequences and often create a need for long-term treatment and care. The... more

Download (10)

View PDF (7)

Enfermedades no transmisibles - Las enfermedades crónicas, no transmisibles (ENT) son la principal causa de muerte y discapacidad en el mundo

Pan American Health Organization PAHO (2024) C_WHO

Download (6)

View PDF (6)

Noncommunicable diseases (NCDs) or Chronic noncommunicable diseases (NCDs) are the 1st cause of death and disability worldwide

World Health Organization WHO (2024) C_WHO

Noncommunicable diseases (NCDs) or Chronic noncommunicable diseases (NCDs) are the 1st cause of death and disability worldwide. The term NCDs refers to a group of conditions that are not mainly caused by an acute infection, result in long-term health consequences and often create a need for long-... more

Download (28)

View PDF (30)

Achieving Control of Asthma in Children in Africa (ACACIA): protocol of an observational study of children’s lung health in six sub-Saharan African countries

Mosler, G.; Oyenuga, V.; Addo-Yobo, E. et al. BMJ Open (2020) CC

Little is known about asthma control in the rising number of African children who suffer from this condition. The Achieving Control of Asthma in Children in Africa (ACACIA) study is an observational study collecting evidence about paediatric asthma in urban areas of Ghana, Malawi, Nigeria, South Afr... more

Download (22)

View PDF (17)

Pathogenesis of chronic obstructive pulmonary disease: An African perspective

Allwood, B.; Calligaro, G. South African Medical Journal (SAMJ) (2015) CC2

The article discusses the significant impact of chronic obstructive pulmonary disease (COPD) as a global health issue, with cigarette smoking as the main risk factor. However, in developing countries, the causes of COPD are often multifactorial, involving environmental tobacco smoke, biomass fuel sm... more

Download (0)

View PDF (0)

Antimicrobial Resistance Surveillance Guidance for the African Region

Africa Center for Disease Control and Prevention (2024) CC

Antimicrobials are medicines, including antibiotics, antivirals, antifungals, and antiparasitics, that are used to prevent and treat infections in humans, animals, and plants. Antimicrobial Resistance (AMR) arises when bacteria, viruses, fungi, and parasites no longer respond to these medicines, ren... more

Understanding refugee trauma: for mental health professionals recommended

Understanding refugee trauma: for mental health professionals
recommended